New Insights into Melanoma and Non-melanoma Skin Cancers
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Dermatology".
Deadline for manuscript submissions: 30 September 2024 | Viewed by 85
Special Issue Editor
Special Issue Information
Dear Colleagues,
The concerning increase in melanoma and non-melanoma skin cancers (NMSCs) requires a renewed focus on early detection and personalized treatment strategies. Recent advances in diagnostics, including state-of-the-art imaging and genetic profiling, have revolutionized our ability to detect and intervene at the earliest stages, improving prognosis and treatment success.
The therapeutic landscape is equally dynamic, with the emergence of immunotherapy and targeted therapies tailored to individual genetic and immunological profiles. This paradigm shift holds significant potential to improve efficacy while minimizing side effects, offering a more precise and patient-centric approach.
Beyond early detection and targeted therapies, ensuring equitable access to care and promoting patient education and empowerment are essential. Telemedicine holds great promise for improving accessibility, facilitating timely interventions, and engaging patients. Additionally, artificial intelligence offers exciting opportunities to refine diagnostics and treatment planning, further personalizing care.
Ultimately, understanding the complexities of these diseases requires robust scientific collaborations that bridge the gap between research and clinical application. Cooperation among clinicians, researchers, and industry stakeholders contributes to a deeper understanding of these diseases and fosters a landscape where scientific knowledge is translated into tangible clinical benefits.
Dr. Andrea Carugno
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- melanoma
- non-melanoma skin cancers (nmsc)
- basal cell carcinoma (bcc)
- squamous cell carcinoma (scc)
- actinic keratosis (ak)
- prevention and early detection
- genetic
- artificial intelligence
- telemedicine
- immunotherapy and targeted therapy
